Bliss GVS Pharma Share Price

Bliss GVS Pharma (INR)108.93-15.5   (-12.4%)

Exchange ScripsBSE506197NSEBLISSGVSISININE416D01022

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Bliss GVS Pharma Performance

Market performance
Open price117.35
High118.9
Volumes2341213
Prev Close108.93
Low106.04
Closing date2024-10-25
Historical performance
1 Year High149.60
3 Year High149.60
5 Year High221.00
1 Year Low81.05
3 Year Low66.10
5 Year Low66.10

Bliss GVS Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1141
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
15.11
Dividend Yield
Dividend Yield
0.46 %

Bliss GVS Pharma Investment Returns

1 Year
35.7%
3 Years
4.6%
5 Years
-19.9%
10 Years
82.2%

Bliss GVS Pharma Technicals

IndicatorsValueSignal
5-DMA123.3Bearish
10-DMA126.79Bearish
20-DMA128.05Bearish
50-DMA128.13Bearish
100-DMA118.94Bearish
200-DMA117.82Bearish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters77777
Foreign Investors---------------
Domestic Investors77777
Public Investors4473045150407514322742175
Government---------------

Bliss GVS Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income304178315220
Operating Profit1794135114981286
Interest691044772
Depreciation264187173172
Profit Before Tax116910615421041
Consolidated Net Profit755709150685
Adjusted EPS7717

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital105104104103
Total Reserves9490864679847881
Minority Interest358335278197
Total Non-Current Liabilities511428292452
Total Liabilities12139115351108710768
Capital Work in Progress782822224
Total Assets12139115351108710768

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities15243431355640
Cash Flow from Investing Activities-1328-78-930-470
Cash Flow from Financing Activitie-209-249-237-208
Net Cash Inflow / Outflow-1316188-38
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 15.11.
  • 3Y Stock Price CAGR of the stock is 0.8.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹1794 Million.
  • The company generated revenue of ₹7702 Million in the previous financial year.

Bliss GVS Pharma

108.93-15.5   (-12.4%)

Investment Amount: ₹ 8430
Current Value: ₹ 10893
Performence: 29.2%
P/L: ₹ 2463
Top Gainers
SymbolChange%
KAMATHOTEL221.86(19%)
SALONA310.3(17%)
TAINWALCHM278.81(14%)
KIRLPNU1472.75(10%)
DPWIRES420.75(7%)
Top Losers
SymbolChange%
INDUSINDBK1041.6(-19%)
POONAWALLA297.05(-17%)
NIBL28.14(-15%)
SURYODAY136.5(-13%)
BLISSGVS108.93(-12%)
DENORA1231.9(-10%)
DIFFNKG356.97(-10%)
GLS938.4(-10%)
Similar stocks

Unichem Lab

19.6

765.6

September 26 - October 26

Windlas Biotech

13

963.4

September 26 - October 26

Neuland Laboratories

10.3

13803.2

September 26 - October 26

Gufic Biosciences

8.4

419.05

September 26 - October 26

Piramal Pharma

8

244.43

September 26 - October 26

Strides Pharma Scien

7.9

1508.85

September 26 - October 26

Divi's Lab

7.2

5780.75

September 26 - October 26

Jagsonpal Pharma

7

451.1

September 26 - October 26

Announcing Stock of the Month!

Stock of the Month
Stock of the Month